Clinical trials
Breast Neoplasms trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
165 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 7 |
| 2007 | 9 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 15 |
| 2022 | 12 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 98 |
| Active, not recruiting | 27 |
| Recruiting | 16 |
| Terminated | 11 |
| Unknown status | 10 |
| Enrolling by invitation | 1 |
| Approved for marketing | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 19 |
| Hoffmann-La Roche | 18 |
| Novartis Pharmaceuticals | 15 |
| Pfizer | 12 |
| Eli Lilly and Company | 9 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 7 |
| Tata Memorial Hospital | 7 |
| Tata Memorial Centre | 4 |
| GlaxoSmithKline | 3 |
| International Agency for Research on Cancer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 165 |
| Neoplasm Metastasis | 16 |
| Neoplasms | 15 |
| Ovarian Neoplasms | 5 |
| Recurrence | 5 |
| Neutropenia | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Brain Neoplasms | 3 |
| Breast Diseases | 3 |
Trials
Showing 26 to 50 of 165. Each trial links to its page on Pharma Observatory.
65 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.